Helen Feng, MD
Rheumatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 25
- 6 carriers
- Office
- 1
Offices
1 location
Plans that list them
25 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Feng’s office at (408) 963-6359 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
25 of 25 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G85995 · Current
Licensed to practise in California · since 2001 · expires 2026-11-30 · New York University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$964,852
Medicare paid this office $964,852 for 315 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, denosumab, 1 mg | 149 | $318,797 | None |
| Long return visit (40+ min) | 303 | $138,873 | $171 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 173 | $51,575 | $60 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 145 | $25,105 | $50 |
| Short return visit | 48 | $21,879 | $57 |
See all 15 services
| Injection, denosumab, 1 mg | 149 | $318,797 | None |
| Long return visit (40+ min) | 303 | $138,873 | $171 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 173 | $51,575 | $60 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 145 | $25,105 | $50 |
| Short return visit | 48 | $21,879 | $57 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 12 | $19,037 | $78 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 69 | $14,620 | $77 |
| Insertion of artery tube for prolonged infusion | 15 | $12,923 | $107 |
| New patient visit (60+ min) | 50 | $10,308 | $206 |
| Injection of drug or substance under skin or into muscle | 159 | $5,853 | $14 |
| Aspiration and/or injection of fluid from large joint | 21 | $4,340 | $57 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 21 | $1,009 | None |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 18 | $276 | $15 |
| Injection, methylprednisolone acetate, 1 mg | 11 | $106 | None |
| Infusion, normal saline solution, 250 cc | 15 | $64 | None |
Who their Medicare patients are
315 Original Medicare patients in 2024. Average age 77 · Under 65 4% · 85 and older 17% · Women 79% · Health risk score 1.10. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 75% · Diabetes 26% · Coronary heart disease 22% · Chronic kidney disease 17% · Atrial fibrillation 17% · Depression 17% · Cancer 16% · COPD 11% · Heart failure 9% · Dementia 8% · Stroke 7%.
The office billed $2,192,850, Medicare allowed $1,214,131 and paid $964,852; for 63,718 services of 35 kinds; $644,886 of it was for drugs given in the office and $319,966 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 315 | 63,718 | 77 | 1.10 | $2,192,850 | $964,852 |
| 2023 | 307 | 52,042 | 76 | 1.05 | $1,738,295 | $794,169 |
| 2022 | 332 | 66,712 | 76 | 1.17 | $2,017,070 | $894,905 |
| 2021 | 362 | 85,570 | 76 | 1.17 | $2,254,725 | $1,053,767 |
| 2020 | 356 | 87,696 | 76 | 1.23 | $2,244,610 | $1,055,086 |
| 2019 | 404 | 84,940 | 76 | 1.20 | $2,332,020 | $1,078,108 |
| 2018 | 376 | 53,987 | 75 | 1.22 | $1,660,427 | $777,380 |
| 2017 | 341 | 52,044 | 75 | 1.24 | $1,871,347 | $893,504 |
| 2016 | 290 | 31,962 | 75 | 1.32 | $1,321,435 | $695,752 |
| 2015 | 265 | 27,405 | 75 | 1.27 | $1,297,465 | $632,883 |
| 2014 | 246 | 18,814 | 75 | 1.28 | $1,008,995 | $494,252 |
| 2013 | 240 | 10,855 | 73 | 1.13 | $442,739 | $273,338 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Injection, denosumab, 1 mg | 152 | $284,418 | None |
| Long return visit (40+ min) | 285 | $116,197 | $162 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 51 | $28,805 | $78 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 57 | $26,187 | $57 |
| Short return visit | 42 | $17,414 | $55 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 11 | $17,040 | $78 |
| Insertion of artery tube for prolonged infusion | 15 | $9,578 | $103 |
| New patient visit (60+ min) | 43 | $8,456 | $197 |
| Injection of drug or substance under skin or into muscle | 160 | $5,166 | $13 |
| Aspiration and/or injection of fluid from large joint | 21 | $3,659 | $54 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 21 | $676 | None |
| Injection, methotrexate sodium, 50 mg | 13 | $421 | None |
| Infusion, normal saline solution, 250 cc | 15 | $51 | None |
2022: 15 services
| Injection, denosumab, 1 mg | 143 | $251,059 | None |
| Long return visit (40+ min) | 306 | $117,057 | $155 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 66 | $30,722 | $58 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 54 | $28,928 | $78 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 14 | $21,660 | $81 |
| Short return visit | 57 | $20,975 | $54 |
| Insertion of artery tube for prolonged infusion | 17 | $11,217 | $107 |
| New patient visit (60+ min) | 40 | $7,698 | $192 |
| Short return visit (20+ min) | 27 | $5,900 | $88 |
| Injection of drug or substance under skin or into muscle | 152 | $5,879 | $14 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 11 | $4,962 | $71 |
| Aspiration and/or injection of fluid from large joint | 21 | $4,467 | $57 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 18 | $542 | None |
| Injection, methotrexate sodium, 50 mg | 16 | $466 | None |
| Infusion, normal saline solution, 250 cc | 18 | $66 | None |
2021: 18 services
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 16 | $283,250 | None |
| Injection, denosumab, 1 mg | 135 | $235,440 | None |
| Long return visit (40+ min) | 332 | $136,031 | $168 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 60 | $33,238 | $78 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 15 | $26,169 | $87 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 85 | $24,709 | $37 |
| Short return visit | 73 | $23,557 | $55 |
| New patient visit (60+ min) | 61 | $12,649 | $207 |
| Insertion of artery tube for prolonged infusion | 18 | $12,433 | $110 |
| Injection of drug or substance under skin or into muscle | 157 | $7,092 | $14 |
| Short return visit (20+ min) | 25 | $7,026 | $89 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 13 | $6,921 | $78 |
| Aspiration and/or injection of fluid from large joint | 28 | $4,848 | $55 |
| Return visit (30+ min) | 14 | $2,545 | $127 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 25 | $1,101 | None |
| Injection, methotrexate sodium, 50 mg | 15 | $509 | None |
| Injection, methylprednisolone acetate, 40 mg | 11 | $110 | None |
| Infusion, normal saline solution, 250 cc | 18 | $69 | None |
2020: 16 services
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 14 | $343,010 | None |
| Injection, denosumab, 1 mg | 130 | $201,665 | None |
| Long return visit (40+ min) | 331 | $101,206 | $133 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 21 | $42,067 | $85 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 115 | $35,362 | $39 |
| Short return visit | 73 | $27,933 | $45 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 48 | $21,422 | $79 |
| Insertion of artery tube for prolonged infusion | 16 | $11,832 | $111 |
| New patient visit (60+ min) | 43 | $7,665 | $178 |
| Injection of drug or substance under skin or into muscle | 158 | $6,989 | $14 |
| Aspiration and/or injection of fluid from large joint | 31 | $5,780 | $55 |
| Short return visit (20+ min) | 18 | $2,603 | $74 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 30 | $1,206 | None |
| Injection, methotrexate sodium, 50 mg | 23 | $914 | None |
| Injection, methylprednisolone acetate, 40 mg | 17 | $163 | None |
| Infusion, normal saline solution, 250 cc | 16 | $60 | None |
2019: 17 services
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 16 | $312,683 | None |
| Injection, denosumab, 1 mg | 136 | $189,852 | None |
| Long return visit (40+ min) | 364 | $112,984 | $132 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 31 | $49,368 | $83 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 124 | $48,081 | $39 |
| Short return visit | 57 | $27,976 | $44 |
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 11 | $20,659 | None |
| New patient visit (60+ min) | 105 | $19,653 | $187 |
| Insertion of artery tube for prolonged infusion | 16 | $12,427 | $108 |
| Injection of drug or substance under skin or into muscle | 176 | $8,574 | $16 |
| Aspiration and/or injection of fluid from large joint | 50 | $8,442 | $50 |
| Short return visit (20+ min) | 27 | $4,339 | $70 |
| Return visit (30+ min) | 14 | $2,089 | $104 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 41 | $1,775 | None |
| Injection, methotrexate sodium, 50 mg | 31 | $1,157 | None |
| Injection, methylprednisolone acetate, 40 mg | 35 | $374 | None |
| Infusion, normal saline solution, 250 cc | 15 | $60 | None |
2018: 16 services
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 12 | $209,706 | None |
| Long return visit (40+ min) | 344 | $111,099 | $133 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 147 | $46,113 | $39 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 29 | $44,765 | $83 |
| Short return visit | 47 | $20,018 | $42 |
| New patient visit (60+ min) | 105 | $19,927 | $190 |
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 13 | $18,501 | None |
| Injection, denosumab, 1 mg | 16 | $14,427 | None |
| Insertion of artery tube for prolonged infusion | 16 | $10,411 | $106 |
| Aspiration and/or injection of fluid from large joint | 46 | $7,920 | $50 |
| Short return visit (20+ min) | 37 | $7,518 | $69 |
| Injection of drug or substance under skin or into muscle | 131 | $7,481 | $20 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 45 | $1,773 | None |
| Injection, methotrexate sodium, 50 mg | 26 | $1,080 | None |
| Injection, methylprednisolone acetate, 40 mg | 23 | $197 | None |
| Infusion, normal saline solution, 250 cc | 14 | $49 | None |
2017: 19 services
| Long return visit (40+ min) | 308 | $97,002 | $129 |
| Injection, denosumab, 1 mg | 68 | $58,869 | None |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 23 | $23,771 | $76 |
| New patient visit (60+ min) | 100 | $17,319 | $173 |
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 11 | $16,477 | None |
| Short return visit | 35 | $13,386 | $41 |
| Insertion of artery tube for prolonged infusion | 20 | $12,655 | $105 |
| Administration of chemotherapy into vein, 1 hour or less | 11 | $10,774 | $144 |
| Injection of drug or substance under skin or into muscle | 133 | $8,972 | $26 |
| Short return visit (20+ min) | 40 | $8,720 | $69 |
| Aspiration and/or injection of fluid from large joint | 52 | $6,800 | $50 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 67 | $6,575 | $40 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 12 | $3,617 | $70 |
| Administration of chemotherapy into vein, each additional hour | 11 | $2,846 | $28 |
| Return visit (30+ min) | 20 | $2,357 | $94 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 51 | $875 | None |
| Injection, methotrexate sodium, 50 mg | 18 | $626 | None |
| Injection, methylprednisolone acetate, 40 mg | 22 | $217 | None |
| Infusion, normal saline solution, 250 cc | 21 | $50 | None |
2016: 15 services
| Injection, denosumab, 1 mg | 86 | $103,700 | None |
| Return visit (30+ min) | 241 | $46,949 | $93 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 87 | $20,660 | $75 |
| Long return visit (40+ min) | 122 | $20,656 | $133 |
| New patient visit (60+ min) | 82 | $15,184 | $185 |
| Administration of chemotherapy into vein, 1 hour or less | 11 | $11,449 | $138 |
| Insertion of artery tube for prolonged infusion | 17 | $11,096 | $110 |
| Short return visit | 39 | $9,887 | $41 |
| Aspiration and/or injection of fluid from large joint | 45 | $5,799 | $49 |
| Injection of drug or substance under skin or into muscle | 84 | $3,269 | $25 |
| Short return visit (20+ min) | 20 | $2,539 | $69 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 41 | $635 | None |
| Injection, methotrexate sodium, 50 mg | 18 | $324 | None |
| Injection, methylprednisolone acetate, 40 mg | 13 | $115 | None |
| Infusion, normal saline solution, 250 cc | 17 | $46 | None |
2015: 17 services
| Injection, infliximab, excludes biosimilar, 10 mg | 11 | $268,602 | None |
| Injection, denosumab, 1 mg | 76 | $80,242 | None |
| Return visit (30+ min) | 244 | $60,437 | $96 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 93 | $25,089 | $77 |
| New patient visit (60+ min) | 73 | $13,600 | $186 |
| Administration of chemotherapy into vein, 1 hour or less | 13 | $12,430 | $137 |
| Insertion of artery tube for prolonged infusion | 21 | $12,112 | $111 |
| Short return visit | 39 | $9,410 | $41 |
| Aspiration and/or injection of fluid from large joint | 44 | $6,727 | $49 |
| Administration of chemotherapy into vein, each additional hour | 11 | $4,635 | $28 |
| Short return visit (20+ min) | 24 | $3,499 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 12 | $2,421 | $71 |
| Injection of drug or substance under skin or into muscle | 33 | $1,281 | $24 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 42 | $643 | None |
| Injection, methotrexate sodium, 50 mg | 16 | $385 | None |
| Injection, methylprednisolone acetate, 40 mg | 24 | $116 | None |
| Infusion, normal saline solution, 250 cc | 22 | $44 | None |
2014: 19 services
| Injection, infliximab, excludes biosimilar, 10 mg | 17 | $260,496 | None |
| Return visit (30+ min) | 223 | $52,483 | $98 |
| Injection, denosumab, 1 mg | 52 | $49,716 | None |
| Insertion of needle or tube into artery of arm or leg | 30 | $26,617 | $274 |
| Administration of chemotherapy into vein, 1 hour or less | 19 | $13,421 | $137 |
| New patient visit (60+ min) | 32 | $6,014 | $188 |
| Aspiration and/or injection of fluid from large joint | 38 | $5,492 | $46 |
| Injection of drug or substance under skin or into muscle | 77 | $5,448 | $25 |
| Administration of chemotherapy into vein, each additional hour | 17 | $4,721 | $28 |
| Insertion of artery tube for prolonged infusion | 19 | $4,416 | $116 |
| Short return visit (20+ min) | 33 | $4,223 | $68 |
| New patient visit (45+ min) | 23 | $3,491 | $152 |
| Injection, zoledronic acid, 1 mg | 12 | $3,097 | None |
| Short return visit | 19 | $2,366 | $42 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 21 | $2,298 | $70 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 25 | $338 | None |
| Injection, methylprednisolone acetate, 40 mg | 34 | $256 | None |
| Injection, methotrexate sodium, 50 mg | 11 | $213 | None |
| Infusion, normal saline solution, 250 cc | 34 | $35 | None |
2013: 15 services
| Injection, infliximab, excludes biosimilar, 10 mg | 16 | $126,270 | None |
| Return visit (30+ min) | 204 | $36,008 | $86 |
| Injection, denosumab, 1 mg | 36 | $25,828 | None |
| Administration of chemotherapy into vein, 1 hour or less | 26 | $14,177 | $139 |
| Aspiration and/or injection of fluid from large joint | 40 | $3,959 | $44 |
| Injection of drug or substance under skin or into muscle | 36 | $3,392 | $25 |
| New patient visit (45+ min) | 22 | $3,116 | $142 |
| New patient visit (60+ min) | 15 | $2,554 | $170 |
| Administration of chemotherapy into vein, each additional hour | 21 | $2,016 | $30 |
| Short return visit (20+ min) | 31 | $1,848 | $58 |
| Injection, triamcinolone hexacetonide, per 5 mg | 22 | $255 | None |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 28 | $248 | None |
| Methotrexate sodium, 5 mg | 12 | $85 | None |
| Injection, methylprednisolone acetate, 80 mg | 13 | $58 | None |
| Infusion, normal saline solution, 250 cc | 26 | $21 | None |
Drugs they prescribed that Part D paid
$1,674,241
Pharmacies billed $1,674,241 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,445 generic and fewer than 11 brand-name prescriptions · $1,674,241 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xeljanz Xr | 29 | $204,582 | $7,055 |
| Enbrel | 23 | $169,234 | $7,358 |
| Prolia | 95 | $164,313 | $1,730 |
| Rinvoq | 21 | $131,657 | $6,269 |
| Orencia | 27 | $112,884 | $4,181 |
See all 34 drugs
| Xeljanz Xr | 29 | $204,582 | $7,055 |
| Enbrel | 23 | $169,234 | $7,358 |
| Prolia | 95 | $164,313 | $1,730 |
| Rinvoq | 21 | $131,657 | $6,269 |
| Orencia | 27 | $112,884 | $4,181 |
| Vascepa | 99 | $93,868 | $948 |
| Enbrel Mini | 12 | $86,855 | $7,238 |
| Orencia Clickject | 12 | $63,894 | $5,325 |
| Benlysta | 13 | $59,254 | $4,558 |
| Tymlos | 21 | $54,182 | $2,580 |
| Kevzara | 11 | $48,021 | $4,366 |
| Rasuvo | 42 | $31,951 | $761 |
| Hydroxychloroquine Sulfate | 381 | $19,490 | $51 |
| Icosapent Ethyl | 25 | $12,140 | $486 |
| Cevimeline | 35 | $9,947 | $284 |
| Lidocaine | 29 | $5,342 | $184 |
| Celecoxib | 83 | $4,843 | $58 |
| Leucovorin | 85 | $4,755 | $56 |
| Diclofenac | 43 | $4,491 | $104 |
| Methotrexate | 136 | $4,024 | $30 |
| Febuxostat | 22 | $2,621 | $119 |
| Mycophenolate Mofetil | 12 | $2,320 | $193 |
| Prednisone | 149 | $1,857 | $12 |
| Gabapentin | 63 | $1,752 | $28 |
| Leflunomide | 18 | $1,377 | $77 |
| Sulfasalazine Dr | 13 | $936 | $72 |
| Duloxetine | 37 | $874 | $24 |
| Alendronate | 110 | $761 | $7 |
| Folic Acid | 46 | $759 | $16 |
| Allopurinol | 34 | $589 | $17 |
| Baclofen | 19 | $458 | $24 |
| Pregabalin | 15 | $356 | $24 |
| Methotrexate | 14 | $243 | $17 |
| Meloxicam | 15 | $36 | $2 |
Year by year
| 2024 | 1,977 | 280 | None | None | $1,674,241 |
| 2023 | 1,792 | 274 | 0% (0) | None | $1,575,452 |
| 2022 | 1,839 | 273 | 0% (0) | 23% | $1,231,980 |
| 2021 | 1,959 | 305 | None | None | $1,139,843 |
| 2020 | 2,384 | 332 | None | None | $1,354,902 |
| 2019 | 2,311 | 356 | 1% (19) | None | $1,482,517 |
| 2018 | 2,337 | 337 | 3% (73) | None | $1,696,190 |
| 2017 | 2,263 | 319 | 4% (79) | None | $3,116,040 |
| 2016 | 1,805 | 242 | 3% (53) | None | $1,600,352 |
| 2015 | 1,597 | 228 | 4% (57) | None | $1,284,728 |
| 2014 | 1,981 | 234 | 4% (84) | 40% | $859,299 |
| 2013 | 1,987 | 210 | 6% (121) | None | $764,907 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Xeljanz Xr | 25 | $175,167 | $7,007 |
| Enbrel | 25 | $171,324 | $6,853 |
| Prolia | 99 | $160,697 | $1,623 |
| Rinvoq | 16 | $99,963 | $6,248 |
| Enbrel Sureclick | 11 | $83,383 | $7,580 |
| Vascepa | 82 | $82,598 | $1,007 |
| Enbrel Mini | 12 | $82,205 | $6,850 |
| Xeljanz | 11 | $68,092 | $6,190 |
| Orencia | 16 | $65,827 | $4,114 |
| Benlysta | 13 | $60,470 | $4,652 |
| Kevzara | 11 | $48,144 | $4,377 |
| Tymlos | 18 | $44,593 | $2,477 |
| Pennsaid | 13 | $34,548 | $2,658 |
| Hydroxychloroquine Sulfate | 361 | $27,457 | $76 |
| Rasuvo | 26 | $17,952 | $690 |
| Icosapent Ethyl | 33 | $17,224 | $522 |
| Diclofenac | 50 | $15,221 | $304 |
| Otrexup | 11 | $10,331 | $939 |
| Cevimeline | 27 | $7,148 | $265 |
| Methotrexate | 142 | $6,802 | $48 |
| Lidocaine | 19 | $5,811 | $306 |
| Celecoxib | 63 | $4,446 | $71 |
| Mycophenolate Mofetil | 13 | $4,144 | $319 |
| Leucovorin | 65 | $3,971 | $61 |
| Febuxostat | 14 | $2,551 | $182 |
| Prednisone | 129 | $2,120 | $16 |
| Leflunomide | 14 | $2,077 | $148 |
| Gabapentin | 61 | $1,970 | $32 |
| Duloxetine | 20 | $801 | $40 |
| Alendronate | 74 | $726 | $10 |
| Allopurinol | 34 | $711 | $21 |
| Baclofen | 24 | $708 | $30 |
| Pregabalin | 15 | $634 | $42 |
| Folic Acid | 41 | $404 | $10 |
| Meloxicam | 22 | $55 | $2 |
2022: 33 drugs
| Enbrel | 29 | $179,723 | $6,197 |
| Prolia | 86 | $125,663 | $1,461 |
| Vascepa | 104 | $97,708 | $940 |
| Rinvoq | 12 | $76,562 | $6,380 |
| Pennsaid | 21 | $55,458 | $2,641 |
| Benlysta | 13 | $55,281 | $4,252 |
| Kevzara | 11 | $45,419 | $4,129 |
| Orencia | 11 | $40,989 | $3,726 |
| Tymlos | 14 | $34,072 | $2,434 |
| Hydroxychloroquine Sulfate | 387 | $34,023 | $88 |
| Diclofenac | 46 | $9,320 | $203 |
| Icosapent Ethyl | 17 | $8,742 | $514 |
| Rasuvo | 12 | $7,886 | $657 |
| Methotrexate | 147 | $7,577 | $52 |
| Cevimeline | 27 | $5,452 | $202 |
| Leucovorin | 72 | $4,479 | $62 |
| Lidocaine | 14 | $4,157 | $297 |
| Celecoxib | 74 | $3,916 | $53 |
| Mycophenolate Mofetil | 12 | $3,162 | $263 |
| Gabapentin | 79 | $2,406 | $30 |
| Pregabalin | 18 | $2,204 | $122 |
| Prednisone | 96 | $2,039 | $21 |
| Duloxetine | 26 | $1,813 | $70 |
| Febuxostat | 20 | $1,487 | $74 |
| Sulfasalazine | 20 | $1,213 | $61 |
| Baclofen | 31 | $894 | $29 |
| Allopurinol | 40 | $876 | $22 |
| Alendronate | 82 | $584 | $7 |
| Folic Acid | 49 | $502 | $10 |
| Methotrexate | 13 | $386 | $30 |
| Ultra-Fine Mini Pen Needle | 13 | $203 | $16 |
| Meloxicam | 22 | $199 | $9 |
| Hydrochlorothiazide | 11 | $118 | $11 |
2021: 33 drugs
| Enbrel | 22 | $128,410 | $5,837 |
| Prolia | 95 | $127,543 | $1,343 |
| Vascepa | 120 | $96,563 | $805 |
| Benlysta | 23 | $85,739 | $3,728 |
| Humira | 13 | $82,873 | $6,375 |
| Humira(Cf) | 12 | $82,872 | $6,906 |
| Pennsaid | 19 | $50,263 | $2,645 |
| Orencia | 12 | $43,019 | $3,585 |
| Tymlos | 18 | $39,710 | $2,206 |
| Hydroxychloroquine Sulfate | 414 | $39,487 | $95 |
| Diclofenac | 79 | $9,447 | $120 |
| Methotrexate | 187 | $8,738 | $47 |
| Lidocaine | 15 | $8,340 | $556 |
| Cevimeline | 29 | $6,841 | $236 |
| Leucovorin | 88 | $5,731 | $65 |
| Mycophenolate Mofetil | 18 | $4,789 | $266 |
| Febuxostat | 17 | $4,114 | $242 |
| Celecoxib | 68 | $3,288 | $48 |
| Leflunomide | 13 | $2,845 | $219 |
| Prednisone | 101 | $2,453 | $24 |
| Gabapentin | 90 | $2,162 | $24 |
| Omega-3 Acid Ethyl Esters | 16 | $1,827 | $114 |
| Baclofen | 41 | $1,318 | $32 |
| Pregabalin | 12 | $943 | $79 |
| Sulfasalazine | 15 | $922 | $61 |
| Allopurinol | 37 | $876 | $24 |
| Azathioprine | 11 | $827 | $75 |
| Duloxetine | 23 | $752 | $33 |
| Alendronate | 73 | $495 | $7 |
| Folic Acid | 48 | $470 | $10 |
| Methotrexate | 14 | $341 | $24 |
| Ibuprofen | 13 | $271 | $21 |
| Meloxicam | 25 | $260 | $10 |
2020: 30 drugs
| Humira(Cf) | 16 | $156,986 | $9,812 |
| Enbrel | 26 | $137,786 | $5,299 |
| Prolia | 98 | $124,931 | $1,275 |
| Vascepa | 205 | $123,945 | $605 |
| Benlysta | 26 | $94,482 | $3,634 |
| Humira | 12 | $69,627 | $5,802 |
| Enbrel Sureclick | 11 | $59,872 | $5,443 |
| Hydroxychloroquine Sulfate | 501 | $55,712 | $111 |
| Kevzara | 13 | $47,501 | $3,654 |
| Orencia | 11 | $38,298 | $3,482 |
| Diclofenac | 156 | $22,679 | $145 |
| Febuxostat | 44 | $14,330 | $326 |
| Methotrexate | 216 | $11,925 | $55 |
| Cevimeline | 31 | $9,207 | $297 |
| Mycophenolate Mofetil | 15 | $6,108 | $407 |
| Leucovorin | 101 | $5,968 | $59 |
| Leflunomide | 28 | $4,094 | $146 |
| Gabapentin | 142 | $3,998 | $28 |
| Prednisone | 157 | $3,788 | $24 |
| Celecoxib | 62 | $3,038 | $49 |
| Baclofen | 72 | $2,821 | $39 |
| Omega-3 Acid Ethyl Esters | 23 | $2,790 | $121 |
| Sulfasalazine Dr | 14 | $1,033 | $74 |
| Sulfasalazine | 12 | $907 | $76 |
| Duloxetine | 20 | $871 | $44 |
| Allopurinol | 37 | $820 | $22 |
| Alendronate | 51 | $592 | $12 |
| Methotrexate | 13 | $350 | $27 |
| Folic Acid | 20 | $292 | $15 |
| Meloxicam | 39 | $278 | $7 |
2019: 31 drugs
| Humira | 27 | $190,289 | $7,048 |
| Enbrel Sureclick | 27 | $141,741 | $5,250 |
| Enbrel | 26 | $129,981 | $4,999 |
| Prolia | 103 | $127,052 | $1,234 |
| Forteo | 30 | $106,206 | $3,540 |
| Vascepa | 139 | $91,060 | $655 |
| Benlysta | 25 | $87,974 | $3,519 |
| Hydroxychloroquine Sulfate | 423 | $62,625 | $148 |
| Orencia | 13 | $42,486 | $3,268 |
| Diclofenac | 95 | $15,997 | $168 |
| Methotrexate | 201 | $12,599 | $63 |
| Uloric | 26 | $12,264 | $472 |
| Febuxostat | 21 | $9,826 | $468 |
| Lyrica | 12 | $8,024 | $669 |
| Cevimeline | 24 | $7,646 | $319 |
| Mycophenolate Mofetil | 12 | $7,158 | $596 |
| Leucovorin | 100 | $5,408 | $54 |
| Celecoxib | 82 | $4,549 | $55 |
| Prednisone | 175 | $4,052 | $23 |
| Colchicine | 14 | $4,028 | $288 |
| Gabapentin | 164 | $3,967 | $24 |
| Omega-3 Acid Ethyl Esters | 24 | $3,758 | $157 |
| Leflunomide | 19 | $2,864 | $151 |
| Baclofen | 87 | $2,424 | $28 |
| Sulfasalazine Dr | 18 | $1,538 | $85 |
| Duloxetine | 37 | $1,363 | $37 |
| Allopurinol | 42 | $863 | $21 |
| Alendronate | 37 | $377 | $10 |
| Meloxicam | 50 | $336 | $7 |
| Tramadol | 13 | $268 | $21 |
| Amlodipine Besylate | 11 | $67 | $6 |
2018: 35 drugs
| Humira | 27 | $205,429 | $7,608 |
| Enbrel Sureclick | 25 | $119,235 | $4,769 |
| Prolia | 97 | $115,062 | $1,186 |
| Enbrel | 14 | $99,879 | $7,134 |
| Benlysta | 29 | $99,481 | $3,430 |
| Forteo | 26 | $86,839 | $3,340 |
| Humira | 12 | $62,443 | $5,204 |
| Hydroxychloroquine Sulfate | 365 | $60,840 | $167 |
| Orencia Clickject | 12 | $52,701 | $4,392 |
| Vascepa | 99 | $52,247 | $528 |
| Remicade | 12 | $50,075 | $4,173 |
| Actemra | 26 | $37,547 | $1,444 |
| Uloric | 57 | $26,655 | $468 |
| Methotrexate | 244 | $21,787 | $89 |
| Lyrica | 19 | $10,659 | $561 |
| Cevimeline | 27 | $9,391 | $348 |
| Diclofenac | 51 | $8,864 | $174 |
| Celecoxib | 86 | $6,253 | $73 |
| Prednisone | 222 | $5,163 | $23 |
| Colchicine | 15 | $4,874 | $325 |
| Omega-3 Acid Ethyl Esters | 24 | $4,564 | $190 |
| Gabapentin | 134 | $4,202 | $31 |
| Leucovorin | 104 | $4,192 | $40 |
| Leflunomide | 11 | $2,821 | $256 |
| Baclofen | 100 | $2,653 | $27 |
| Oseltamivir Phosphate | 29 | $2,509 | $87 |
| Azathioprine | 28 | $2,108 | $75 |
| Sulfasalazine Dr | 25 | $1,361 | $54 |
| Duloxetine | 31 | $1,033 | $33 |
| Allopurinol | 37 | $772 | $21 |
| Tramadol | 28 | $702 | $25 |
| Hydrocodone-Acetaminophen | 24 | $407 | $17 |
| Tizanidine | 12 | $349 | $29 |
| Meloxicam | 41 | $265 | $6 |
| Alendronate | 12 | $150 | $13 |
2017: 39 drugs
| H.P. Acthar | 35 | $1,786,264 | $51,036 |
| Humira | 29 | $237,419 | $8,187 |
| Enbrel | 22 | $135,952 | $6,180 |
| Prolia | 117 | $127,484 | $1,090 |
| Enbrel Sureclick | 23 | $105,830 | $4,601 |
| Hydroxychloroquine Sulfate | 333 | $80,123 | $241 |
| Forteo | 27 | $77,896 | $2,885 |
| Remicade | 17 | $64,329 | $3,784 |
| Orencia Clickject | 16 | $62,171 | $3,886 |
| Humira | 12 | $52,924 | $4,410 |
| Benlysta | 13 | $39,208 | $3,016 |
| Vascepa | 44 | $23,424 | $532 |
| Methotrexate | 240 | $21,595 | $90 |
| Uloric | 40 | $19,056 | $476 |
| Lyrica | 17 | $12,250 | $721 |
| Otrexup | 16 | $9,598 | $600 |
| Rasuvo | 21 | $9,265 | $441 |
| Celecoxib | 94 | $8,757 | $93 |
| Diclofenac | 46 | $7,688 | $167 |
| Cevimeline | 25 | $7,632 | $305 |
| Leflunomide | 23 | $7,445 | $324 |
| Voltaren | 27 | $6,068 | $225 |
| Lidocaine | 16 | $5,538 | $346 |
| Omega-3 Acid Ethyl Esters | 28 | $5,371 | $192 |
| Colchicine | 18 | $4,810 | $267 |
| Prednisone | 168 | $4,160 | $25 |
| Leucovorin | 97 | $4,111 | $42 |
| Gabapentin | 125 | $3,168 | $25 |
| Duloxetine | 44 | $2,195 | $50 |
| Azathioprine | 28 | $1,883 | $67 |
| Baclofen | 98 | $1,826 | $19 |
| Sulfasalazine Dr | 14 | $1,079 | $77 |
| Allopurinol | 34 | $1,029 | $30 |
| Alendronate | 15 | $832 | $55 |
| Oxycodone-Acetaminophen | 12 | $812 | $68 |
| Tizanidine | 14 | $588 | $42 |
| Tramadol | 24 | $457 | $19 |
| Hydrocodone-Acetaminophen | 22 | $346 | $16 |
| Meloxicam | 44 | $220 | $5 |
2016: 38 drugs
| H.P. Acthar | 18 | $623,412 | $34,634 |
| Enbrel | 62 | $300,787 | $4,851 |
| Humira | 19 | $134,465 | $7,077 |
| Orencia | 20 | $72,158 | $3,608 |
| Simponi | 16 | $60,709 | $3,794 |
| Hydroxychloroquine Sulfate | 255 | $58,814 | $231 |
| Forteo | 18 | $50,680 | $2,816 |
| Benlysta | 23 | $31,733 | $1,380 |
| Prolia | 19 | $19,382 | $1,020 |
| Otrexup | 18 | $14,007 | $778 |
| Uloric | 27 | $13,566 | $502 |
| Vascepa | 33 | $13,242 | $401 |
| Omega-3 Acid Ethyl Esters | 42 | $12,194 | $290 |
| Voltaren | 53 | $12,064 | $228 |
| Methotrexate | 149 | $11,638 | $78 |
| Lidocaine | 26 | $10,567 | $406 |
| Cevimeline | 23 | $7,574 | $329 |
| Leflunomide | 18 | $7,383 | $410 |
| Lyrica | 15 | $6,544 | $436 |
| Celecoxib | 49 | $6,454 | $132 |
| Rasuvo | 12 | $5,370 | $448 |
| Gabapentin | 130 | $4,267 | $33 |
| Leucovorin | 92 | $3,800 | $41 |
| Duloxetine | 55 | $3,754 | $68 |
| Colchicine | 11 | $3,569 | $324 |
| Prednisone | 161 | $3,307 | $21 |
| Diclofenac | 14 | $2,968 | $212 |
| Tizanidine | 12 | $2,320 | $193 |
| Mycophenolate Mofetil | 13 | $2,253 | $173 |
| Baclofen | 78 | $1,571 | $20 |
| Sulfasalazine Dr | 15 | $866 | $58 |
| Allopurinol | 27 | $765 | $28 |
| Tramadol Hcl-Acetaminophen | 12 | $755 | $63 |
| Azathioprine | 18 | $733 | $41 |
| Hydrocodone-Acetaminophen | 17 | $508 | $30 |
| Alendronate | 11 | $357 | $32 |
| Meloxicam | 43 | $213 | $5 |
| Tramadol | 11 | $125 | $11 |
2015: 32 drugs
| Enbrel | 75 | $247,396 | $3,299 |
| Humira | 24 | $125,671 | $5,236 |
| Orencia | 24 | $75,976 | $3,166 |
| Forteo | 30 | $72,502 | $2,417 |
| Simponi | 16 | $56,512 | $3,532 |
| Hydroxychloroquine Sulfate | 212 | $51,133 | $241 |
| Prolia | 21 | $19,802 | $943 |
| Omega-3 Acid Ethyl Esters | 42 | $16,301 | $388 |
| Methotrexate | 120 | $15,144 | $126 |
| Lidoderm | 17 | $14,624 | $860 |
| Lidocaine | 24 | $10,569 | $440 |
| Cevimeline | 25 | $10,264 | $411 |
| Uloric | 19 | $10,125 | $533 |
| Lovaza | 13 | $9,288 | $714 |
| Voltaren | 46 | $9,276 | $202 |
| Vascepa | 28 | $7,988 | $285 |
| Celecoxib | 31 | $7,389 | $238 |
| Duloxetine | 79 | $6,736 | $85 |
| Gabapentin | 126 | $4,252 | $34 |
| Colcrys | 11 | $4,108 | $373 |
| Mycophenolate Mofetil | 13 | $2,378 | $183 |
| Leucovorin | 62 | $2,347 | $38 |
| Prednisone | 108 | $1,745 | $16 |
| Sulfasalazine Dr | 20 | $1,731 | $87 |
| Leflunomide | 12 | $1,403 | $117 |
| Allopurinol | 38 | $894 | $24 |
| Hydrocodone-Acetaminophen | 22 | $843 | $38 |
| Azathioprine | 22 | $629 | $29 |
| Baclofen | 30 | $473 | $16 |
| Tramadol Hcl-Acetaminophen | 13 | $428 | $33 |
| Amlodipine Besylate | 12 | $90 | $8 |
| Meloxicam | 11 | $53 | $5 |
2014: 37 drugs
| Enbrel | 58 | $156,991 | $2,707 |
| Humira | 25 | $110,391 | $4,416 |
| Forteo | 58 | $100,271 | $1,729 |
| Lidoderm | 61 | $42,258 | $693 |
| Simponi | 14 | $40,265 | $2,876 |
| Lovaza | 92 | $34,955 | $380 |
| Orencia | 13 | $34,533 | $2,656 |
| Orencia | 15 | $29,640 | $1,976 |
| Prolia | 33 | $28,878 | $875 |
| Voltaren | 137 | $26,954 | $197 |
| Lidocaine | 35 | $19,155 | $547 |
| Celebrex | 51 | $18,765 | $368 |
| Methotrexate | 149 | $14,446 | $97 |
| Duloxetine | 65 | $13,805 | $212 |
| Cevimeline | 44 | $12,073 | $274 |
| Lidocaine-Prilocaine | 31 | $10,529 | $340 |
| Hydroxychloroquine Sulfate | 248 | $9,926 | $40 |
| Uloric | 17 | $8,099 | $476 |
| Omega-3 Acid Ethyl Esters | 23 | $7,889 | $343 |
| Lyrica | 19 | $6,398 | $337 |
| Butrans | 12 | $5,760 | $480 |
| Colcrys | 18 | $5,619 | $312 |
| Gabapentin | 132 | $4,970 | $38 |
| Vascepa | 15 | $4,483 | $299 |
| Leucovorin | 57 | $2,408 | $42 |
| Prednisone | 116 | $2,099 | $18 |
| Leflunomide | 13 | $1,264 | $97 |
| Hydrocodone-Acetaminophen | 31 | $791 | $26 |
| Tramadol | 27 | $447 | $17 |
| Bd Ultra-Fine Pen Needle | 13 | $420 | $32 |
| Baclofen | 26 | $408 | $16 |
| Allopurinol | 25 | $377 | $15 |
| Sulfazine Ec | 12 | $348 | $29 |
| Methocarbamol | 13 | $347 | $27 |
| Azathioprine | 18 | $305 | $17 |
| Alendronate | 11 | $128 | $12 |
| Meloxicam | 16 | $70 | $4 |
2013: 41 drugs
| Humira | 36 | $114,110 | $3,170 |
| Enbrel | 45 | $107,989 | $2,400 |
| Forteo | 60 | $77,514 | $1,292 |
| Lidoderm | 72 | $53,381 | $741 |
| Lovaza | 134 | $39,970 | $298 |
| Simponi | 16 | $38,427 | $2,402 |
| Orencia | 14 | $29,204 | $2,086 |
| Orencia | 12 | $27,676 | $2,306 |
| Xeljanz | 13 | $27,489 | $2,115 |
| Cymbalta | 94 | $25,588 | $272 |
| Prolia | 26 | $21,662 | $833 |
| Voltaren | 125 | $21,178 | $169 |
| Celebrex | 45 | $16,540 | $368 |
| Methotrexate | 142 | $12,560 | $88 |
| Lidocaine | 11 | $9,382 | $853 |
| Hydroxychloroquine Sulfate | 261 | $7,615 | $29 |
| Cevimeline | 23 | $7,274 | $316 |
| Uloric | 24 | $6,663 | $278 |
| Colcrys | 24 | $5,955 | $248 |
| Lyrica | 20 | $5,617 | $281 |
| Butrans | 15 | $5,399 | $360 |
| Gabapentin | 95 | $3,523 | $37 |
| Mycophenolate Mofetil | 16 | $3,466 | $217 |
| Leucovorin | 58 | $2,625 | $45 |
| Savella | 11 | $1,845 | $168 |
| Prednisone | 120 | $1,563 | $13 |
| Tramadol Hcl-Acetaminophen | 25 | $1,559 | $62 |
| Leflunomide | 17 | $1,443 | $85 |
| Tamiflu | 11 | $1,179 | $107 |
| Hydrocodone-Acetaminophen | 33 | $960 | $29 |
| Baclofen | 44 | $796 | $18 |
| Tramadol | 36 | $765 | $21 |
| Methocarbamol | 14 | $351 | $25 |
| Meloxicam | 25 | $332 | $13 |
| Sulindac | 13 | $327 | $25 |
| Nabumetone | 15 | $247 | $16 |
| Azathioprine | 11 | $231 | $21 |
| Acetaminophen-Codeine | 12 | $228 | $19 |
| Alendronate | 23 | $211 | $9 |
| Folic Acid | 31 | $196 | $6 |
| Allopurinol | 15 | $144 | $10 |
Money from drug and device companies
$5,136 in 2025
| 2025 | 19 | 181 | None | $5,136 |
| 2024 | 18 | 230 | None | $6,048 |
| 2023 | 20 | 221 | None | $5,069 |
| 2022 | 18 | 202 | None | $3,903 |
| 2021 | 17 | 189 | None | $3,447 |
| 2020 | 18 | 126 | None | $2,785 |
| 2019 | 25 | 346 | None | $7,167 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $1,142 | 23 payments
|
| Amgen | Otezla | $990 | 53 payments
|
| Ucb | Bimzelx | $570 | 12 payments
|
| Radius Health | Tymlos | $354 | 10 payments
|
| Janssen Biotech | Tremfya | $296 | 15 payments
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $285 | 17 payments
|
See all 181 published payments
| Abbvie | Meals · 2025-12-28 | Rinvoq | $9 |
| Radius Health | Meals · 2025-12-22 | Tymlos | $30 |
| GlaxoSmithKline | Meals · 2025-12-16 | Benlysta | $4 |
| GlaxoSmithKline | Meals · 2025-12-16 | Benlysta | $7 |
| GlaxoSmithKline | Meals · 2025-12-16 | Benlysta | $19 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-16 | Saphnelo | $30 |
| Amgen | Meals · 2025-12-15 | Otezla | $7 |
| Abbvie | Meals · 2025-12-12 | Rinvoq | $28 |
| Amgen | Meals · 2025-12-11 | Otezla | $6 |
| ANI Pharmaceuticals | Meals · 2025-12-05 | Purified Cortrophin Gel | $27 |
| Novartis Pharmaceuticals | Meals · 2025-12-04 | Cosentyx | $28 |
| Abbvie | Meals · 2025-11-25 | Rinvoq | $5 |
| Ucb | Meals · 2025-11-24 | Bimzelx | $45 |
| Amgen | Meals · 2025-11-24 | Otezla | $8 |
| ANI Pharmaceuticals | Meals · 2025-11-24 | Purified Cortrophin Gel | $24 |
| Mallinckrodt Hospital Products | Meals · 2025-11-21 | Acthar | $11 |
| Abbvie | Meals · 2025-11-20 | Skyrizi | $122 |
| Amgen | Meals · 2025-11-20 | Evenity | $28 |
| Amgen | Meals · 2025-11-18 | Uplizna | $12 |
| Genzyme | Meals · 2025-11-18 | Kevzara | $33 |
| Amgen | Meals · 2025-11-17 | Otezla | $22 |
| Novartis Pharmaceuticals | Meals · 2025-11-06 | Cosentyx | $33 |
| Mallinckrodt Hospital Products | Meals · 2025-11-03 | Acthar | $38 |
| Amgen | Meals · 2025-11-03 | Otezla | $7 |
| Novartis Pharmaceuticals | Meals · 2025-10-30 | Cosentyx | $27 |
| Abbvie | Meals · 2025-10-30 | Rinvoq | $6 |
| Aurinia Pharma U.S. | Meals · 2025-10-24 | Lupkynis | $27 |
| Amgen | Meals · 2025-10-23 | Tavneos | $13 |
| Amgen | Meals · 2025-10-21 | Krystexxa | $14 |
| ANI Pharmaceuticals | Meals · 2025-10-21 | Purified Cortrophin Gel | $19 |
| Amgen | Meals · 2025-10-20 | Otezla | $7 |
| Radius Health | Meals · 2025-10-20 | Tymlos | $30 |
| Amgen | Meals · 2025-10-16 | Uplizna | $41 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-15 | Saphnelo | $26 |
| Amgen | Meals · 2025-10-13 | Otezla | $29 |
| GlaxoSmithKline | Meals · 2025-10-10 | Benlysta | $30 |
| Abbvie | Meals · 2025-10-09 | Rinvoq | $116 |
| Novartis Pharmaceuticals | Meals · 2025-10-06 | Cosentyx | $29 |
| Amgen | Meals · 2025-10-06 | Otezla | $7 |
| Mallinckrodt Hospital Products | Meals · 2025-09-25 | Acthar | $38 |
| Amgen | Meals · 2025-09-25 | Otezla | $6 |
| Ucb | Meals · 2025-09-23 | Bimzelx | $38 |
| Amgen | Meals · 2025-09-15 | Otezla | $28 |
| ANI Pharmaceuticals | Meals · 2025-09-15 | Purified Cortrophin Gel | $24 |
| Novartis Pharmaceuticals | Meals · 2025-09-11 | Cosentyx | $12 |
| Abbvie | Meals · 2025-09-11 | Rinvoq | $22 |
| Amgen | Meals · 2025-09-11 | Evenity | $22 |
| Amgen | Meals · 2025-09-08 | Otezla | $7 |
| GlaxoSmithKline | Meals · 2025-09-03 | Benlysta | $32 |
| Abbvie | Meals · 2025-08-28 | None | $122 |
| Radius Health | Meals · 2025-08-28 | Tymlos | $32 |
| Abbvie | Meals · 2025-08-27 | Rinvoq | $20 |
| Janssen Biotech | Meals · 2025-08-26 | Tremfya | $12 |
| InSightec | Meals · 2025-08-26 | Exablate | $143 |
| Janssen Biotech | Meals · 2025-08-25 | Tremfya | $5 |
| Amgen | Meals · 2025-08-25 | Otezla | $7 |
| Mallinckrodt Hospital Products | Meals · 2025-08-19 | Acthar | $39 |
| GlaxoSmithKline | Meals · 2025-08-18 | Benlysta | $22 |
| Abbvie | Meals · 2025-08-15 | Skyrizi | $27 |
| Amgen | Meals · 2025-08-14 | Uplizna | $31 |
| ANI Pharmaceuticals | Meals · 2025-08-14 | Purified Cortrophin Gel | $13 |
| Janssen Biotech | Meals · 2025-08-12 | Tremfya | $5 |
| Pfizer | Meals · 2025-08-12 | Xeljanz | $26 |
| Amgen | Meals · 2025-08-11 | Otezla | $29 |
| Aurinia Pharma U.S. | Meals · 2025-08-07 | Lupkynis | $27 |
| Amgen | Meals · 2025-08-06 | Uplizna | $19 |
| Abbvie | Meals · 2025-08-05 | Rinvoq | $9 |
| Amgen | Meals · 2025-08-04 | Otezla | $6 |
| ANI Pharmaceuticals | Meals · 2025-07-31 | Purified Cortrophin Gel | $13 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-29 | Saphnelo | $27 |
| Amgen | Meals · 2025-07-28 | Otezla | $8 |
| Radius Health | Meals · 2025-07-24 | Tymlos | $32 |
| Amgen | Meals · 2025-07-22 | Tavneos | $29 |
| Amgen | Meals · 2025-07-21 | Otezla | $7 |
| Janssen Biotech | Meals · 2025-07-15 | Tremfya | $35 |
| Amgen | Meals · 2025-07-15 | Uplizna | $8 |
| Genzyme | Meals · 2025-07-15 | Kevzara | $39 |
| Amgen | Meals · 2025-07-14 | Otezla | $24 |
| ANI Pharmaceuticals | Meals · 2025-07-14 | Purified Cortrophin Gel | $14 |
| GlaxoSmithKline | Meals · 2025-07-08 | Benlysta | $24 |
| Novartis Pharmaceuticals | Meals · 2025-07-07 | Cosentyx | $34 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-27 | Saphnelo | $6 |
| Abbvie | Meals · 2025-06-26 | Rinvoq | $15 |
| ANI Pharmaceuticals | Meals · 2025-06-23 | Purified Cortrophin Gel | $12 |
| Radius Health | Meals · 2025-06-23 | Tymlos | $32 |
| Radius Health | Education · 2025-06-23 | Tymlos | $8 |
| Abbvie | Meals · 2025-06-19 | Rinvoq | $122 |
| Ucb | Meals · 2025-06-19 | Bimzelx | $30 |
| Aurinia Pharma U.S. | Meals · 2025-06-19 | Lupkynis | $30 |
| Janssen Biotech | Meals · 2025-06-18 | Tremfya | $32 |
| ANI Pharmaceuticals | Meals · 2025-06-18 | Purified Cortrophin Gel | $7 |
| Amgen | Meals · 2025-06-16 | Otezla | $27 |
| Pfizer | Meals · 2025-06-12 | Xeljanz | $32 |
| Ucb | Meals · 2025-06-11 | Bimzelx | $76 |
| Amgen | Meals · 2025-06-09 | Otezla | $7 |
| Amgen | Meals · 2025-06-09 | Krystexxa | $21 |
| Novartis Pharmaceuticals | Meals · 2025-06-05 | Cosentyx | $11 |
| Amgen | Meals · 2025-06-02 | Otezla | $7 |
| Ucb | Meals · 2025-05-29 | Bimzelx | $45 |
| Janssen Biotech | Meals · 2025-05-28 | Tremfya | $39 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-27 | Saphnelo | $23 |
| Amgen | Meals · 2025-05-27 | Otezla | $8 |
| Abbvie | Meals · 2025-05-23 | Skyrizi | $35 |
| Ucb | Meals · 2025-05-23 | Bimzelx | $10 |
| Aurinia Pharma U.S. | Meals · 2025-05-20 | Lupkynis | $30 |
| Amgen | Meals · 2025-05-19 | Otezla | $7 |
| GlaxoSmithKline | Meals · 2025-05-16 | Benlysta | $29 |
| Amgen | Meals · 2025-05-13 | None | $21 |
| ANI Pharmaceuticals | Meals · 2025-05-13 | Purified Cortrophin Gel | $7 |
| Amgen | Meals · 2025-05-12 | Otezla | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-08 | Saphnelo | $30 |
| Fresenius Kabi USA | Meals · 2025-05-07 | None | $14 |
| Novartis Pharmaceuticals | Meals · 2025-05-06 | Cosentyx | $29 |
| Amgen | Meals · 2025-05-05 | Otezla | $11 |
| Sanofi-Aventis U.S. | Education · 2025-05-01 | Kevzara | $100 |
| Radius Health | Meals · 2025-04-29 | Tymlos | $30 |
| Radius Health | Meals · 2025-04-29 | Tymlos | $96 |
| Lilly USA | Meals · 2025-04-28 | Taltz | $31 |
| Abbvie | Meals · 2025-04-24 | Rinvoq | $125 |
| Aurinia Pharma U.S. | Meals · 2025-04-24 | Lupkynis | $18 |
| Aurinia Pharma U.S. | Meals · 2025-04-24 | Lupkynis | $3 |
| Ucb | Meals · 2025-04-23 | Bimzelx | $42 |
| Amgen | Meals · 2025-04-21 | Otezla | $7 |
| Ucb | Meals · 2025-04-17 | Bimzelx | $125 |
| ANI Pharmaceuticals | Meals · 2025-04-15 | Purified Cortrophin Gel | $9 |
| Amgen | Meals · 2025-04-14 | Otezla | $27 |
| Janssen Biotech | Meals · 2025-04-10 | Tremfya | $15 |
| Abbvie | Meals · 2025-04-10 | None | $124 |
| Amgen | Meals · 2025-04-08 | Otezla | $11 |
| Amgen | Meals · 2025-04-08 | Krystexxa | $28 |
| ANI Pharmaceuticals | Meals · 2025-04-07 | Purified Cortrophin Gel | $10 |
| Genentech USA | Meals · 2025-04-01 | Actemra | $36 |
| Amgen | Meals · 2025-03-28 | Tavneos | $23 |
| Aurinia Pharma U.S. | Meals · 2025-03-27 | Lupkynis | $26 |
| GlaxoSmithKline | Meals · 2025-03-26 | Benlysta | $27 |
| Novartis Pharmaceuticals | Meals · 2025-03-24 | Cosentyx | $32 |
| Abbvie | Meals · 2025-03-20 | Rinvoq | $20 |
| Ucb | Meals · 2025-03-20 | Bimzelx | $24 |
| ANI Pharmaceuticals | Meals · 2025-03-20 | Purified Cortrophin Gel | $30 |
| Janssen Biotech | Meals · 2025-03-17 | Tremfya | $12 |
| Janssen Biotech | Meals · 2025-03-17 | Tremfya | $24 |
| Pfizer | Meals · 2025-03-17 | Xeljanz | $22 |
| Abbvie | Meals · 2025-03-13 | Rinvoq | $28 |
| Amgen | Meals · 2025-03-10 | Otezla | $10 |
| Janssen Biotech | Meals · 2025-03-06 | Tremfya | $13 |
| Amgen | Meals · 2025-03-06 | Tavneos | $26 |
| ANI Pharmaceuticals | Meals · 2025-03-04 | Purified Cortrophin Gel | $20 |
| Amgen | Meals · 2025-03-03 | Otezla | $16 |
| Janssen Biotech | Meals · 2025-02-28 | Tremfya | $31 |
| Janssen Biotech | Meals · 2025-02-27 | Tremfya | $3 |
| Abbvie | Meals · 2025-02-27 | Rinvoq | $11 |
| Abbvie | Meals · 2025-02-27 | Skyrizi | $119 |
| GlaxoSmithKline | Meals · 2025-02-25 | Benlysta | $30 |
| Novartis Pharmaceuticals | Meals · 2025-02-24 | Cosentyx | $23 |
| Amgen | Meals · 2025-02-20 | None | $39 |
| ANI Pharmaceuticals | Meals · 2025-02-20 | Purified Cortrophin Gel | $20 |
| Ucb | Meals · 2025-02-18 | Bimzelx | $50 |
| Aurinia Pharma U.S. | Meals · 2025-02-12 | Lupkynis | $21 |
| Abbvie | Meals · 2025-02-11 | Rinvoq | $10 |
| Amgen | Meals · 2025-02-11 | Otezla | $11 |
| Radius Health | Meals · 2025-02-11 | Tymlos | $31 |
| Ucb | Meals · 2025-02-07 | Bimzelx | $40 |
| Amgen | Meals · 2025-02-06 | Otezla | $120 |
| Amgen | Meals · 2025-02-04 | Krystexxa | $29 |
| Amgen | Meals · 2025-02-03 | Enbrel | $11 |
| Ucb | Meals · 2025-01-28 | Bimzelx | $45 |
| Amgen | Meals · 2025-01-27 | Otezla | $18 |
| Janssen Biotech | Meals · 2025-01-23 | Tremfya | $40 |
| Janssen Biotech | Meals · 2025-01-23 | Tremfya | $2 |
| ANI Pharmaceuticals | Meals · 2025-01-23 | Purified Cortrophin Gel | $18 |
| Almatica Pharma | Meals · 2025-01-22 | Teriparatide | $29 |
| Janssen Biotech | Meals · 2025-01-17 | Tremfya | $28 |
| Abbvie | Meals · 2025-01-16 | Rinvoq | $13 |
| GlaxoSmithKline | Meals · 2025-01-14 | Benlysta | $27 |
| Abbvie | Meals · 2025-01-14 | Rinvoq | $33 |
| Amgen | Meals · 2025-01-13 | Enbrel | $6 |
| ANI Pharmaceuticals | Meals · 2025-01-10 | Purified Cortrophin Gel | $17 |
| Mallinckrodt Hospital Products | Meals · 2025-01-09 | Acthar | $35 |
| Amgen | Meals · 2025-01-09 | Evenity | $35 |
| Amgen | Meals · 2025-01-06 | Enbrel | $10 |
| Radius Health | Meals · 2025-01-06 | Tymlos | $31 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $6,048
| Amgen | Enbrel | $1,255 | 65 payments
|
| Abbvie | Rinvoq | $895 | 28 payments
|
| Ucb | Cimzia | $663 | 14 payments
|
| Janssen Biotech | Tremfya | $590 | 25 payments
|
| Mallinckrodt Hospital Products | Acthar | $549 | 12 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $293 | 7 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $290 | 11 payments
|
| Radius Health | Tymlos | $249 | 6 payments
|
| Novartis Pharmaceuticals | Cosentyx | $228 | 9 payments
|
| Boehringer Ingelheim Pharmaceuticals | Cyltezo | $217 | 4 payments
|
| GlaxoSmithKline | Benlysta | $194 | 8 payments
|
| Fresenius Kabi USA | Idacio | $181 | 8 payments
|
| Pfizer | Xeljanz | $166 | 8 payments
|
| Alexion Pharmaceuticals | Strensiq | $98 | 3 payments
|
| Aurinia Pharma U.S. | Lupkynis | $83 | 3 payments
|
| Lilly USA | Taltz | $35 | 1 payment
|
| Genzyme | Kevzara | $32 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Orencia | $29 | 1 payment
|
2023: $5,069
| Amgen | Enbrel | $1,176 | 66 payments
|
| Ucb | Cimzia | $741 | 24 payments
|
| Abbvie | Rinvoq | $707 | 31 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $534 | 17 payments
|
| Janssen Biotech | Tremfya | $514 | 19 payments
|
| GlaxoSmithKline | Benlysta | $263 | 9 payments
|
| Pfizer | Xeljanz | $256 | 14 payments
|
| Novartis Pharmaceuticals | Cosentyx | $193 | 8 payments
|
| Radius Health | Tymlos | $131 | 5 payments
|
| Horizon Therapeutics plc | Krystexxa | $126 | 5 payments
|
| Mallinckrodt Hospital Products | Acthar | $86 | 4 payments
|
| Aurinia Pharma U.S. | Lupkynis | $81 | 3 payments
|
| Lilly USA | Taltz | $60 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Cyltezo | $43 | 2 payments
|
| Octapharma USA | Panzyga | $39 | 1 payment
|
| Fresenius Kabi USA | Idacio | $36 | 1 payment
|
| Genentech USA | Actemra | $33 | 1 payment
|
| Amarin Pharma | Vascepa | $23 | 1 payment
|
| DePuy Synthes Sales | Orthovisc | $22 | 1 payment
|
| Hospira | Octagam Immune Globulin (Human) | $3 | 1 payment
|
2022: $3,903
| Amgen | Enbrel | $774 | 54 payments
|
| Janssen Biotech | Tremfya | $428 | 17 payments
|
| Ucb | Cimzia | $383 | 15 payments
|
| Abbvie | Rinvoq | $376 | 24 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $343 | 16 payments
|
| Pfizer | Xeljanz | $287 | 12 payments
|
| GlaxoSmithKline | Benlysta | $261 | 11 payments
|
| Horizon Therapeutics plc | Rayos | $182 | 10 payments
|
| Exeltis USA | Purified Cortrophin Gel | $169 | 8 payments
|
| Mallinckrodt Hospital Products | Acthar | $166 | 8 payments
|
| Radius Health | Tymlos | $127 | 4 payments
|
| Amarin Pharma | Vascepa | $109 | 5 payments
|
| Novartis Pharmaceuticals | Cosentyx | $88 | 5 payments
|
| Aurinia Pharma U.S. | Lupkynis | $82 | 3 payments
|
| Hospira | Octagam Immune Globulin (Human) | $64 | 3 payments
|
| Lilly USA | Taltz | $32 | 1 payment
|
| Bioventus | Gelsyn-3 | $18 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Orencia | $14 | 1 payment
|
2021: $3,447
| AbbVie | Rinvoq | $636 | 41 payments
|
| Amgen | Enbrel | $552 | 30 payments
|
| Pfizer | Xeljanz | $349 | 16 payments
|
| Mallinckrodt Hospital Products | Acthar | $272 | 17 payments
|
| Janssen Biotech | Tremfya | $248 | 19 payments
|
| GlaxoSmithKline | Benlysta | $243 | 9 payments
|
| Ucb | Cimzia | $219 | 9 payments
|
| Horizon Therapeutics plc | Krystexxa | $217 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $183 | 9 payments
|
| Amarin Pharma | Vascepa | $127 | 6 payments
|
| Novartis Pharmaceuticals | Cosentyx | $111 | 10 payments
|
| Radius Health | Tymlos | $89 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $56 | 3 payments
|
| Aurinia Pharma U.S. | Lupkynis | $51 | 2 payments
|
| Antares Pharma | Otrexup | $37 | 2 payments
|
| Bioventus | Gelsyn-3 | $29 | 1 payment
|
| Lilly USA | Taltz | $26 | 1 payment
|
2020: $2,785
| Amgen | Enbrel | $496 | 20 payments
|
| Mallinckrodt Hospital Products | Acthar | $261 | 12 payments
|
| GlaxoSmithKline | Benlysta | $247 | 9 payments
|
| AbbVie | Humira | $237 | 12 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $222 | 5 payments
|
| Genzyme | Kevzara | $202 | 9 payments
|
| Amarin Pharma | Vascepa | $180 | 11 payments
|
| Horizon Therapeutics plc | Krystexxa | $161 | 10 payments
|
| Antares Pharma | Otrexup | $143 | 9 payments
|
| Pfizer | Xeljanz | $140 | 7 payments
|
| Janssen Biotech | Simponi Aria | $120 | 7 payments
|
| Ucb | Cimzia | $103 | 3 payments
|
| Radius Health | Tymlos | $100 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $46 | 2 payments
|
| Janssen Scientific Affairs | Simponi Aria | $43 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $32 | 2 payments
|
| Akcea Therapeutics | Tegsedi | $28 | 1 payment
|
| Medexus Pharma | Rasuvo | $24 | 1 payment
|
2019: $7,167
| AbbVie | Humira | $1,050 | 38 payments
|
| Amgen | Enbrel | $971 | 50 payments
|
| Horizon Therapeutics plc | Rayos | $886 | 46 payments
|
| Novartis Pharmaceuticals | Cosentyx | $505 | 18 payments
|
| Mallinckrodt Enterprises | Acthar | $427 | 25 payments
|
| Pfizer | Xeljanz | $425 | 22 payments
|
| GlaxoSmithKline | Benlysta | $347 | 15 payments
|
| Janssen Biotech | Simponi Aria | $294 | 19 payments
|
| Akcea Therapeutics | Tegsedi | $253 | 4 payments
|
| Celgene | Otezla | $250 | 12 payments
|
| Amarin Pharma | Vascepa | $245 | 25 payments
|
| Genzyme | Kevzara | $234 | 10 payments
|
| Antares Pharma | Otrexup | $224 | 18 payments
|
| Janssen Scientific Affairs | Simponi Aria | $212 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $169 | 9 payments
|
| Medexus Pharma | Rasuvo | $147 | 7 payments
|
| Ucb | Cimzia | $145 | 8 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $88 | 3 payments
|
| Gilead Sciences | None | $88 | 4 payments
|
| Radius Health | Tymlos | $50 | 2 payments
|
| Lilly USA | Taltz | $39 | 2 payments
|
| Boston Scientific | General Therapies | $39 | 1 payment
|
| Zyla Life Sciences | Zorvolex | $34 | 2 payments
|
| Genentech USA | Rituxan | $23 | 1 payment
|
| Hikma Pharmaceuticals USA | Mitigare | $23 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Janssen Research & Development, LLC · Comparative and Pragmatic Study of Simponi Aria Versus · 2021 | Their institution | $2,249 |
| Janssen Research & Development, LLC · Comparative and Pragmatic Study of Simponi Aria Versus · 2020 | Their institution | $2,038 |
Checkups this office reported
8 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 91.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 9%That's few of the people this applied to. | 237 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 55%That's more than half. | 139 |
| Checked for fall riskOlder patients screened for fall risk | 88%That's most of the people this applied to. | 350 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 84%That's most of the people this applied to. Worse on this measure. | 38 |
| Medications listed in the chartVisits where the current medication list was documented | 98%That's most of the people this applied to. | 682 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 340 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 72% | 398 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 82%That's most of the people this applied to. | 365 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Patient Medication Risk Education
Professional record
- NPI
- 1629174149
- Licence
- CA G85995California G85995: Current · expires 2026-11-30
- Trained
- New York University School of Medicine, 1987
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X)
- Mailing address
- 2242 Camden Ave, Ste 200, San Jose, CA, 95124
- NPI first listed
- 2006-09-15
- NPI last updated
- 2023-03-07
This is when the NPI record was last certified, not a medical board exam.